View in EDS

Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer.

Saved in:
Bibliographic Details
Title: Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer.
Authors: de Mooij CM; Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands., Simons JM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., van Amstel FJG; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands. Electronic address: florien.vanamstel@maastrichtuniversity.nl., Mitea C; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Nelemans PJ; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands., Mottaghy FM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany., van der Pol CC; Department of Surgical Oncology, Alrijne Hospital, Leiderdorp, the Netherlands., Luiten EJT; Department of Surgery, Amphia Hospital Breda, Breda, the Netherlands; Department of Surgery, College of Medicine and Health Sciences, United Arab Emirates University, Abu Dhabi Emirate, Al Ain, United Arab Emirates., Koppert LB; Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Smidt ML; Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands., van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW - Research Institute for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
Corporate Authors: REFINE Study Group
Source: Breast (Edinburgh, Scotland) [Breast] 2026 Apr; Vol. 86, pp. 104718. Date of Electronic Publication: 2026 Jan 31.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-3080
DOI:10.1016/j.breast.2026.104718